External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

HSG 2025

-
Coming soon
01:00 PM
Duration 60mins Nashville, USA
Development of a long-read phasing assay for allele-specific patient inclusion for Roche HTT SNP ASO program
A Rautanen, S Calus, N Giroud, M Araujo, S Dziadek, T Kam-Thong, M Sultan, C Imboden, P McColgan, D Hawellek

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Nashville, USA
Longitudinal assessment of upper limb chorea in Huntington’s disease using smartwatch-based passive monitoring
Claire Lugrin, Lidia Alecci, Cedric Simillion, Ekaterina Volkova-Volkmar, Louis-Solal Giboin, Fiona C Kinsella, Peter McColgan, Ed Wild, Jonas Dorn

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
03:00 PM
Duration 90mins Nashville
Toward disease-modifying treatments in HD: An update from Roche
Peter McColgan

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 90mins Nashville
When research assays become decision tools - (m)HTT and NfL
David Hawellek

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar